Eisai at a Glance

A company that changes society through creating medicines and providing various innovative solutions that change society.

Eisai Co., Ltd. - The Parent Company

The story of Eisai Co., Ltd (“Eisai”) began even before it bore its current name, when its entrepreneurial founder Toyoji Naito launched his pharmaceutical career by marketing imported drugs to the Japanese public in the early 20th century. His inexhaustible drive to improve the people’s access to groundbreaking medicine continues to permeate all aspects of Eisai’s operations globally, and as the company continues to expand its reach to many communities in need, its pioneering hhc (“human health care”) philosophy remains its core guiding principle.

Formally established in 1941 and headquartered in Tokyo, Japan, Eisai has since grown to become a leading global research and development-based pharmaceutical company, operating over 40 subsidiaries and employing more than 10,000 employees worldwide. Its continued commitment to improve lives is grounded in rigorous scientific research and its hhc philosophy, which emphasises the need for all its employees to spend 1% of their working hours with patients.

Owing to its founder’s early ambition to source and develop effective medicine to combat widespread ailments, Eisai is thus resolute in its mission to assist many communities in need worldwide by banking on its strategic partnerships and existing expertise to rapidly improve healthcare infrastructure and access. Having established neurology and oncology as areas of focus, Eisai aims to tackle diseases for which treatments are yet to be fully available. By actively concentrating R&D resources in these areas, Eisai continues to dedicate itself to discovering new and highly effective treatments. Eisai is a publicly traded company on the Tokyo Stock Exchange.

Eisai In Numbers

Ensuring our 1 true goal of placing our patients and their families first above all else is actualised across all our operations.

15

Operating 15 drug discovery, research and development, clinical research sites.

40

Overseeing more than 40 subsidiaries worldwide.

80

Improving lives for over 80 years.

> 10,000

More than 10,000 employees worldwide

645.9 bil

Generated 645.9 billion in revenue (FY2020).

15

Operating 15 drug discovery, research and development, clinical research sites.

40

Overseeing more than 40 subsidiaries worldwide.

80

Improving lives for over 80 years.

> 10,000

More than 10,000 employees worldwide

645.9 bil

Generated 645.9 billion in revenue (FY2020).

Eisai (Malaysia) Sdn Bhd - A Subsidiary

A pharmaceutical subsidiary of Eisai Co., Ltd., Eisai Malaysia celebrated its golden jubilee in 2019 to mark the corporation’s presence and growth in the country since 1969. Inspired by the history and expansion of its parent company in Japan, Eisai Malaysia continues to champion and advocate for universal access to innovative medicines.

Eisai Malaysia is steadfast in its commitment to be the pioneering hhc company in the nation, firm in the belief that the people’s health cannot be approached as a mere statistic, but as a holistic experience that is capable of transforming communities, beyond healing the individual patient. To that end, Eisai Malaysia is indebted to the selfless and unsung heroes who have helped to grow the company’s
influence and outreach, allowing previously untapped communities to benefit its scientific endeavours.

Eisai Malaysia looks forward to continuing its strategic collaborations with stakeholders and partners, including healthcare providers, to fulfil its corporate objective for the next 50 years and beyond.

Corporate Philosophy

We give first thought to patients and their families, and to increasing the benefits health care providers.

We are, first and foremost, a company for the people. Eisai Malaysia has always been principally guided by the belief that innovative healthcare solutions should always be readily accessible by all who need them, which is why we’ll continue to leverage on our extensive network and expertise to elevate the human health care experience in the nation.

Corporate Objective

A human health care company capable of making meaningful contributions under any healthcare system while observing the highest legal and ethical standards in business activities.

We aspire to be a socially and environmentally conscious enterprise, and the key to that is to ultimately create a sustainable society well equipped with the necessary resources for efficient disease management.

Press Release

January 22, 2024

EISAI (MALAYSIA) SDN. BHD. PARTNERS WITH TOKIO MARINE INSURANS (MALAYSIA) BERHAD AND PMCARE SDN. BHD. TO ENHANCE ACCESS TO ALZHEIMER'S DISEASE TREATMENTS AND PROMOTE AWARENESS OF AD, DEMENTIA, AND BRAIN HEALTH IN MALAYSIA

Message From The Managing Director

Kam Ai Teng, Managing Director

At Eisai Malaysia, we believe that leadership is nothing without compassion.

To this day, we continue to be inspired by the stories we have heard from those on the medical frontlines and strive to elevate the lives of each and every patient that we have had the fortune to help. By completely embracing our predecessors emphasis on establishing a human health care culture, all of our leaders at Eisai Malaysia persist in encouraging our teams to slow down, listen, and understand the needs of every patient. It only takes a single act of kindness to achieve a breakthrough.

In line with that sentiment, we are dedicated to cultivating a diverse, supportive, and progressive group. After all, the work begins first from within, thus necessitating the need for a conducive working environment that stimulates the collaborative spirit and drives innovation. It is an understatement to say that we are proud of the team we’ve managed to nurture over the years, and who have continued to spread that kindness forward through the state-of-art products we provide.

After all, Eisai is a global leading research-based pharmaceutical company with a focus in neurology and oncology. To say that we are obsessed to discover novel medication and methods to treat enigmatic diseases is an understatement. If anything, we choose to be defined by our relentless pursuit for ground-breaking medicines and effective therapy, all in the name to improve the people’s access to greater healthcare.